TBIO OTC
Telesis Bio, Inc.
1W: -99.1%
1M: -90.0%
3M: -99.8%
YTD: -99.8%
1Y: -99.2%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$35M
+10.5% ▲
Capital Expenditures
$2M
+55.7% ▲
5Y CAGR: -21.4%
Free Cash Flow
-$37M
+15.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$29M
+44.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$18M | -$39M | -$48M | -$48M |
| Depreciation & Amort. | $857K | $1M | $2M | $3M | $4M |
| Stock-Based Comp. | $13K | $43K | $1M | $4M | $4M |
| Change in Working Capital | $225K | -$20K | -$3M | $2M | -$8M |
| Other Non-Cash Items | $1M | $706K | $333K | $1M | $13M |
| Operating Cash Flow | -$6M | -$15M | -$37M | -$39M | -$35M |
| — Investing Activities — | |||||
| Capital Expenditures | -$79K | -$204K | -$2M | -$4M | -$2M |
| Acquisitions (Net) | $0 | $0 | -$13M | -$556K | $16K |
| Investment Purchases | -$174M | $0 | $0 | -$77M | -$34M |
| Investment Sales | $160M | $0 | $0 | $64M | $30M |
| Other Investing | $15M | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$79K | -$204K | -$15M | -$18M | -$6M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$107K | $10M | $5M | -$15M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $35M | $0 | -$1M | -$700K | $8M |
| Financing Cash Flow | $35M | -$96K | $121M | $5M | $12M |
| Net Change in Cash | -$27M | -$16M | $69M | -$52M | -$29M |
| Cash End of Period | $29M | $13M | $83M | $31M | $2M |
| Free Cash Flow | -$6M | -$16M | -$39M | -$43M | -$37M |